Clinical Trial Update: Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial validating a plasma transfusion dosing algorithm in patients with chronic liver disease has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Snippet

Sponsor: University of Colorado, Denver | Conditions: Liver Disease | Phase 4 | Status: COMPLETED | Results posted: 2019-10-29